Based on the provided data, the antibacterial medicine use in Australia shows a decreasing trend from 2024 to 2028. In 2023, the actual value stood at approximately 17.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. The forecasted data for 2024 starts at 17.1 and progressively declines to 16.4 by 2028.
Year-on-year variations indicate the following changes: from 2023 to 2024 the usage decreases by about 1.16%, from 2024 to 2025 by approximately 1.17%, from 2025 to 2026 by around 0.59%, from 2026 to 2027 by roughly 1.19%, and from 2027 to 2028 by about 1.20%. The average compound annual growth rate (CAGR) for the period from 2024 to 2028 is around -1.04% per year, indicating a consistent decline in usage.
Future trends to watch for include the impact of stricter antibiotic stewardship programs, public health initiatives focused on reducing unnecessary antibiotic use, and the development of new antiviral treatments that might further decrease dependence on antibacterial medications. Additionally, advancements in diagnostic technologies for infections could also contribute to this declining trend by enabling more precise use of antibiotics.
